VALERIS ANNOUNCES ENHANCEMENTS TO ITS EXECUTIVE LEADERSHIP TEAM

Premier life sciences commercialization partner hires Jodi Dickinson and Peter Formisano

JEFFERSONVILLE, Ind. and MORRISVILLE, N.C., July 8, 2025 /PRNewswire/ — Valeris, a fully integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain, today announced two appointments that further strengthens the company’s senior leadership team. Formed from the May 2025 merger of PharmaCord and Mercalis, Valeris has named Jodi Dickinson Chief People Officer (CPO) and Peter Formisano Chief Operating Officer (COO).

Dickinson possesses nearly three decades of Human Resources leadership experience and has spent the last 12 years as a Chief Human Resources Officer (CHRO) and Executive Team Member across a range of industries, including SaaS, biotech, and education. She most recently served as CHRO at Frontline Technologies. Her deep expertise in culture, engagement, and organizational growth will be instrumental as Valeris continues to scale and strengthen its people-first foundation. Jodi’s commitment to cultivating mission-driven cultures embodies the very essence of Valeris’s values and will be a driving force in shaping its future. She holds a BS in Psychology from Pennsylvania State University, an MS in Human Resource Development from Villanova University, and an HR certification from Cornell University.

Formisano is a proven C-level executive with a distinguished record of driving organizational transformation, operational excellence, and sustainable growth across healthcare and technology organizations. He most recently served as COO for InteLogix, where he led global operations for over 5000 agents and focused on customer experience and patient support. His interest in AI-driven innovation, operational excellence, and customer-first solutions will accelerate Valeris’s ability to build on its strengths and deliver cutting-edge solutions that elevate experiences for patients, providers, and life sciences partners. Formisano earned a BBA in Accounting and Management Information Systems from Iona University.

“The addition of Jodi and Peter further strengthens the Valeris leadership team,” said Robert Truckenmiller, CEO of Valeris. “For many years, both individuals have demonstrated excellence in their fields and are very highly respected among their peers. “I look forward to the many contributions they will make going forward.”

About Valeris

Valeris is a fully integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company works on behalf of life sciences companies to improve the patient experience so that patients can access and adhere to critical medications. Backed by proven industry expertise, a deep commitment to patient care, the latest technology, and exceptionally talented team members, Valeris provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Valeris provides commercialization solutions to more than 500 life sciences customers and has provided access and affordability support to millions of patients. The company is headquartered in Morrisville, North Carolina and Jeffersonville, Indiana. To learn more about Valeris, please visit www.valeris.com.

Contact:
Landy Townsend
VP, Marketing & Communications
Valeris
ltownsend@mercalis.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/valeris-announces-enhancements-to-its-executive-leadership-team-302493527.html

SOURCE Valeris

Staff

Recent Posts

MEDITECH Announces the Passing of Founder and Chairman A. Neil Pappalardo

Reflections on his 56-year legacy as a tech pioneer and founder of the EHR industryCANTON,…

3 hours ago

eClinicalWorks and Sunoh.ai Assist Healthy Horizons Clinic Save Over Two Hours Daily on Clinical Documentation

Multispecialty practice transforms patient care, improves operational efficiency, and increases patient engagement with AI medical…

3 hours ago

TRNR Publishes Comprehensive Sportstech Documentation for Shareholders

Timeline and Source Materials Now Available at interactivestrength.com/sportstech AUSTIN, TEXAS / ACCESS Newswire / January…

3 hours ago

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…

6 hours ago

Hologic Announces Financial Results for First Quarter of Fiscal 2026

– Revenue of $1,047.8 Million Grows 2.5% – – GAAP Diluted EPS of $0.79 Decreases…

6 hours ago

Illumina completes acquisition of SomaLogic

Deeply expands leadership in proteomics and multiomicsCombined capabilities bring high scalability, flexibility, and affordability into protein…

6 hours ago